FEDERAL COURT OF AUSTRALIA
Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002
Citation: Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002 Parties: WAKE FOREST UNIVERSITY HEALTH SCIENCES and KCI MEDICAL AUSTRALIA PTY LTD (ACN 056 073 468) v SMITH & NEPHEW PTY LTD (ACN 000 087 507); SMITH & NEPHEW PTY LTD (ACN 000 087 507); WAKE FOREST UNIVERSITY HEALTH SCIENCES and KCI MEDICAL AUSTRALIA PTY LTD (ACN 056 073 468) File number: VID 143 of 2009 Judge: DODDS-STREETON J Date of judgment: 30 August 2011 Catchwords: PATENTS – Method and apparatus for treating wounds unlikely to heal by the use of conventional methods through negative pressure wound therapy – Common general knowledge as at priority date – Construction of claims – Meaning of integer of screen means “sufficiently rigid to prevent wound overgrowth” – Meaning of integer of screen means “sufficiently porous” to allow gases or oxygen to reach the wound – Meaning of integer of “migration of epithelial and subcutaneous tissue toward the wound” – Whether various integers essential
PATENTS – Infringement – Whether direct or indirect infringement – Whether respondent liable as joint tortfeasor – Whether respondent’s products possessed screen means sufficiently rigid to prevent wound overgrowth – Whether respondent’s products possessed other integers
PATENTS – Validity – Novelty – Whether prior art anticipated claims in suit – Whether claims in suit anticipated by prior use of open drainage system
PATENTS – Validity – Inventive step – Whether invention obvious to skilled addressee – Construction of Patents Act 1990 (Cth) ss 7(2) and (3) – Whether prior art comparator to be considered as starting point for obviousness
PATENTS – Validity – Other grounds of alleged invalidity – Whether claims in suit fairly based on matter described in specification – Whether priority date deferred – Whether invention a manner of manufacture or comprised of mere clinical desiderata – Whether invention properly defined – Whether claims invalid for lack of clarity – Whether claims invalid for lack of sufficiency – Whether claim invalid as a mere collocation
Legislation: Evidence Act 1995 (Cth) s 140
Patents Act 1990 (Cth) ss 7, 13, 18(1), 40(2), 40(3), 102(2)(a), 114, 117, 138(3), Schedule 1Patents Regulations 1991 (Cth) reg 3.14
Cases cited: Abbott Laboratories & Anor v Corbridge Group Pty Ltd & Anor (2002) 57 IPR 432 cited
Advanced Building Systems Pty Ltd & Anor v Ramset Fasteners (Aust) Pty Ltd (1998) 194 CLR 171 cited
Ajinomoto Company Inc v NutraSweet Australia Pty Ltd (2008) 166 FCR 530 cited
Aktiebolaget Hässle v Alphapharm Pty Ltd (2000) 51 IPR 375 cited
Aktiebolaget Hässle & Anor v Alphapharm Pty Ltd (2002) 212 CLR 411 discussed
Alphapharm Pty Ltd v H Lundbeck A/S & Anor (2008) 76 IPR 618 cited
Anaesthetic Supplies Pty Ltd v Rescare Ltd (1994) 50 FCR 1 considered
Apotex Pty Ltd v Sanofi Aventis (2008) 78 IPR 485 cited
Apotex Pty Ltd v Sanofi-Aventis (2009) 82…
Keep reading for free
Create a free CaseChat account to read Wake Forest University Health Sciences v Smith & Nephew Pty... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2011] FCA 1002
- Decision Date
CaseChat Overview and Summary
The central legal issues involved the construction of the patent claims, the infringement of these claims by S&N's products, and the validity of the claims under the Patents Act 1990 (Cth). The court had to decide whether the claims were clear and sufficiently described, whether they were novel and inventive, and whether they were anticipated by prior art. The claims' validity also depended on whether they were fairly based on the matter described in the specification, whether the invention was a manner of manufacture, and whether the claims were clear and sufficient. The court had to determine if S&N's products directly or indirectly infringed the patent and whether S&N was liable as a joint tortfeasor.
The court found that the claims were invalid due to the essential integer of screen rigidity being fundamentally flawed, as it lacked clarity and specificity. This flaw rendered the claims invalid under sections 40(2) and (3) of the Patents Act 1990 (Cth). The court concluded that the skilled addressee would attribute no meaning to this integer, which was crucial for the validity of the claims. Consequently, the court ruled that the application should be dismissed, and the cross-claim should be allowed. The court invited submissions on the form of orders and costs.
Orders
Orders of the court
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi